Title

Attention deficit/hyperactivity disorder and methylphenidate - A review of height/weight, cardiovascular, and somatic complaint side effects

Authors

Authors

M. D. Rapport;C. Moffitt

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Clin. Psychol. Rev.

Keywords

DEFICIT HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED EVALUATION; DOSE-RESPONSE; ADHD CHILDREN; HYPERKINETIC CHILDREN; CLASSROOM; PERFORMANCE; SOCIAL-BEHAVIOR; GROWTH; ADOLESCENTS; BOYS; Psychology, Clinical

Abstract

Three classes (height/weight, cardiovascular, and somatic complaints) of treatment emergent symptoms (side effects) associated with methylphenidate (MPH) therapy for children with attention deficit/hyperactivity disorder (ADHD) are reviewed. The more easily quantifiable side effects (e.g., blood pressure [BP], heart rate [HR], height/weight) are mostly transient, dose-dependent, easily rectified with dosage adjustments, and considered minor from a clinical perspective considering the breadth and level of improvement in behavior and cognitive functioning observed in most children. Previously reported somatic complaints associated with psychostimulant therapy may reflect symptoms occurring prior to initiation of treatment and require additional study. (C) 2002 Elsevier Science Ltd. All rights reserved.

Journal Title

Clinical Psychology Review

Volume

22

Issue/Number

8

Publication Date

1-1-2002

Document Type

Review

Language

English

First Page

1107

Last Page

1131

WOS Identifier

WOS:000178946200001

ISSN

0272-7358

Share

COinS